Figure 4.
(Graphical Abstract). Proposed mechanism depicting CCL20 – mediated immunosuppression via PD-L1+ neutrophils. Tumor-derived CCL20 activates and induces PD-L1 expression on neutrophils. These neutrophils inhibited T cell functions via PD-L1 in breast cancer